Inspire(US:INSP) TMX Newsfile·2025-12-25 13:30Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. due to allegations of misleading statements regarding the launch of its Inspire V device, which has led to significant financial losses for investors [2][4]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses in Inspire Medical to contact them to discuss legal options, particularly in light of a federal securities class action with a deadline of January 5, 2026, for seeking the role of lead plaintiff [1][2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 2: Allegations Against Inspire Medical - The complaint alleges that Inspire Medical and its executives violated federal securities laws by making false and misleading statements about the market demand for the Inspire V device and the company's readiness for its launch [4]. - On August 4, 2025, Inspire Medical announced significant setbacks in the launch of the Inspire V device, citing delays due to incomplete training and onboarding at treatment centers, as well as billing and reimbursement challenges [5]. Group 3: Financial Impact - Inspire Medical reported weak demand and excess inventory for the Inspire V device, leading to a drastic cut in its 2025 earnings guidance by over 80% [6]. - Following the announcement of these issues, Inspire's stock price plummeted by more than 32%, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025, resulting in a loss of approximately $1.2 billion in market capitalization [6].